The Ethical Case for Decentralized Clinical Trials.

Autor: Muyskens K; Research fellow at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore., Teo IZY; Research assistant at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore., Menikoff J; Professor of bioethics at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore and a Senior Fellow in the Faculty of Law at the National University of Singapore., Schaefer GO; Assistant professor of ethics at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore.

Publikováno v: Ethics & human research [Ethics Hum Res] 2024 Nov-Dec; Vol. 46 (6), pp. 14-24.

Sustainability in the pandemic accord.

Autor: Schaefer GO; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore owen_schaefer@nus.edu.sg., Emanuel E; Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Persad G; University of Denver, Denver, Colorado, USA., Smith MJ; Faculty of Health Sciences, University of Western Ontario, London, Ontario, Canada.

Publikováno v: BMJ global health [BMJ Glob Health] 2024 Jun 30; Vol. 9 (6). Date of Electronic Publication: 2024 Jun 30.

Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability

Autor: Moon, S, Armstrong, J, Hutler, B, Upshur, R, Katz, R, Atuire, C, Bhan, A, Emanuel, E, Faden, R, Ghimire, P, Greco, D, Ho, CW, Kochhar, S, Schaefer, GO, Shamsi-Gooshki, E, Singh, JA, Smith, MJ, Wolff, J

Publikováno v: Lancet (London, England)

The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1ee483a908652f3ca463583101c1eca
https://doi.org/10.1016/s0140-6736(21)02344-8

The importance of getting the ethics right in a pandemic treaty.

Autor: Schaefer GO; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Atuire CA; Nufflield Department of Medicine, University of Oxford, Oxford, UK; Department of Philosophy and Classics, University of Ghana, Accra, Ghana., Kaur S; Faculty of Law, Universiti Malaya, Kuala Lumpur, Malaysia., Parker M; The Ethox Centre and the Pandemic Sciences Institute, University of Oxford, Oxford, UK., Persad G; University of Denver Sturm College of Law, Denver, CO, USA., Smith MJ; School of Health Studies, Western University, London, ON, Canada., Upshur R; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Emanuel E; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: zemanuel@upenn.edu.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Nov; Vol. 23 (11), pp. e489-e496. Date of Electronic Publication: 2023 Jul 05.

Funder priority for vaccines: Implications of a weak Lockean claim.

Autor: Muralidharan A; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Schaefer GO; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Johnson T; Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK., Savulescu J; Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.

Publikováno v: Bioethics [Bioethics] 2022 Nov; Vol. 36 (9), pp. 978-988. Date of Electronic Publication: 2022 Aug 19.